
Dotmatics
@dotmatics
Followers
1K
Following
512
Media
1K
Statuses
3K
Discover why 2 million scientists and 10,000 leading scientific R&D enterprises trust Dotmatics to connect science, data, and decision-making.
Dotmatics HQ 🖥️👩🏽🔬💊🧬
Joined May 2010
Don’t miss our latest on-demand webinar: Connected for a Cure: Precision Oncology in the Age of AI and Data-Driven Collaboration! . 💡 Discover how data driven science and hashtag#AI are transforming oncology drug discovery.
dotmatics.com
Explore how data, AI, and collaboration are transforming oncology drug discovery in this on-demand fireside chat with leaders from Dotmatics and Sygnature Discovery. Watch to learn how to build an...
0
0
2
💡 What should every life sciences CIO focus on in 2025?. From navigating #AI integration to enabling connected data, we break down the 6 essential priorities CIOs must tackle, and how to stay ahead in a rapidly evolving R&D landscape.
dotmatics.com
Life sciences CIOs are under pressure to modernize R&D. Discover the 6 key priorities for 2025, from eliminating data silos to enabling AI-ready workflows.
0
0
1
🔬 Discover how Sygnature Discovery is accelerating research with Dotmatics!. 📖 Read the full case study now:
dotmatics.com
Discover how Sygnature Discovery improved lab efficiency, data accessibility, and client reporting by implementing the Dotmatics ELN and Data Discovery Platform.
0
0
1
Dotmatics has been featured in a recent U.S. News & World Report article exploring how AI is driving innovation in healthcare and life sciences.
dotmatics.com
Discover how Dotmatics is helping accelerate drug discovery and improve patient care with AI-powered scientific platforms. Read the full U.S. News featured article.
0
0
2
Dotmatics’ VP of Science & Technology, Philip Mounteney has been feautred on NBC Louisiana in discussion on how artificial intelligence is transforming the future of drug discovery. Read the full article:
dotmatics.com
Discover how Dotmatics is using AI to accelerate drug discovery and reduce time to market. Watch the full Louisiana First News interview with Dotmatics’ Head of Science & Tech.
0
0
2
📰 In a recent article by ABC News7, Philip Mounteney shares how Dotmatics is using #AI to streamline preclinical research, speed up mRNA development, and help scientists make better, faster decisions to help speed up drug discovery.
dotmatics.com
Discover how Dotmatics is using AI to transform drug discovery and accelerate scientific research. Read the full ABC News article highlighting our impact on preclinical development and data-driven...
0
0
1
🚨 New eBook alert!. 📘 Beyond SDMS: Unlocking Real ROI with Intelligent R&D Technology. This eBook explores how forward-thinking teams are moving beyond legacy systems to unlock real ROI with intelligent, AI-ready data infrastructure. Download now!
dotmatics.com
Discover how to move beyond traditional SDMS with AI-ready infrastructure that accelerates insights, boosts compliance, and drives real ROI.
0
0
2
Want to learn about what's new in Dotmatics ELN & Data Discovery 7.3?. Watch our on demand webinar hosted by Gianpaolo Bravi and Troy Humphreys here: to learn about the latest updates!.
dotmatics.com
Discover the latest features in Dotmatics ELN & Data Discovery 7.3. Watch the on-demand webinar to see how new enhancements streamline workflows, improve data integration, and accelerate scientific...
0
0
1
In our blog, we discuss the hidden costs of disconnected tools, data silos, and fragmented systems in scientific research. Dotmatics helps overcome these hurdles by unifying your digital ecosystem to accelerate discovery and drive better outcomes.
dotmatics.com
Reduce R&D inefficiencies with Dotmatics’ AI-powered platform for data management and workflow automation and its portfolio of specialty science software.
0
0
1
In a CBS News New York interview, Dotmatics VP of Science and Technology, Philip Mounteney, shares how #AI is reshaping the drug discovery process—helping researchers accelerate timelines, reduce costs, and deliver safer, more effective therapies to market.
dotmatics.com
Discover how Dotmatics is using AI to accelerate early-phase drug discovery and development—enabling safer, faster, and more cost-effective therapies. Watch the full interview to learn more.
0
0
2
🚨 Big News from @LabArchives 🚨 . LabArchives for Government is now FedRAMP Authorized at the Moderate impact level. This is a major milestone in secure, compliant data management for U.S. federal agencies. 🔗 Learn more:
dotmatics.com
LabArchives for Government ELN, Inventory, and Scheduler are FedRAMP-authorized for use in managing unclassified U.S. federal data.
0
0
3
📰 News Alert: Discover how Dotmatics is helping scientists unlock faster, smarter research with AI-powered solutions in this article by Lab Manager, "AI in the Lab: Faster, Smarter Drug Discovery" featuring Christian Olsen, Dotmatics VP of Strategy.
dotmatics.com
Discover how AI is transforming drug discovery in the lab. In this featured article, Dotmatics’ Christian Olsen shares insights on how AI accelerates research, enhances data analysis, and drives...
0
0
3
🚀Exciting news: Dotmatics has signed an agreement to be acquired by @Siemens. Together, we’ll connect scientific design, discovery & manufacturing — helping life sciences teams accelerate innovation and impact.
0
5
8
📣 Don't miss our upcoming webinar: Lab Instrument Harmonization with Luma Lab Connect, on April 24th, 2025. 🔗 Register now:
dotmatics.zoom.us
Scientific discovery has never been more complex, or more data-driven. Yet many labs still struggle with fragmented systems, manual data entry, and costly custom integrations that slow down R&D and...
0
0
1
📺 In this recent @ABC30 interview, our VP of Science & Technology, Philip Mounteney, shares how Dotmatics AI-powered solutions are accelerating research, reducing costs, and helping scientists get life-saving medicines to patients faster.
abc30.com
Artificial Intelligence is making its mark on the world around us in a variety of ways, including drug research.
0
1
3
One of the biggest hurdles researchers are still facing is moving data across the their research workflow. Dotmatics Luma + OMIQ integration streamlines your workflow, automates dataflows, and accelerates analysis—so you can focus on discoveries.
dotmatics.com
Integrating Dotmatics Luma and OMIQ accelerates flow cytometry workflows from instrument data acquisition to advanced flow cytometry data analysis.
0
0
3
💡 Dotmatics Luma is redefining drug discovery with #AI!. Your ELN just got smarter—integrating AI-powered insights, private & public datasets, and predictive modeling to accelerate breakthroughs in the lab. Learn how Luma is powering innovation.
dotmatics.com
Discover how Dotmatics Luma combines AI with your ELN to accelerate drug discovery. Learn about its cutting-edge predictions, molecule sourcing, and private data integration.
0
1
2
#AI is transforming life sciences, but unlocking its full potential in 2025 takes more than just technology—it requires better data strategies, smarter workflows, and seamless AI integration.💡. Dotmatics and @databricks are making this a reality.
dotmatics.com
Discover how Dotmatics and Databricks are transforming scientific R&D by unifying data, AI, and automation. Learn how to overcome data silos, improve data trust, and accelerate discovery with...
0
0
2